438.66
                                            
                                Überblick
                                Nachrichten
                                Preisverlauf
                                    Optionskette
                                Financials
                                    Warum fällt UTHR?
                                Forum
                                Prognose
                                    Aktiensplit
                        
                        United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease - The Joplin Globe
United Therapeutics (Nasdaq: UTHR) starts EXPAND with first UKidney xenotransplant - Stock Titan
Can technical indicators confirm United Therapeutics Corporation’s reversalWeekly Stock Report & High Accuracy Swing Trade Signals - newser.com
United Therapeutics Hits Day High with 9.63% Surge in Stock Price - Markets Mojo
Is United Therapeutics Corporation (UTH) stock a top dividend aristocrat candidateRisk Management & Reliable Entry Point Trade Alerts - newser.com
MSN Money - MSN
United Therapeutics Corp. Hits New 52-Week High of $479.50 - Markets Mojo
United Therapeutics posts record revenue but misses Q3 earnings expectations - MSN
Focus Partners Advisor Solutions LLC Buys Shares of 1,440 United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corp’s Earnings Call Highlights Growth and Innovation - MSN
United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
3rd Circ. Preview: BMW, MiLB And Sandoz Top Nov. Lineup - Law360
United Therapeutics (NASDAQ:UTHR) Given New $423.00 Price Target at Wells Fargo & Company - MarketBeat
Assetmark Inc. Boosts Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Will United Therapeutics Corporation stock benefit from upcoming earnings reportsOptions Play & Technical Pattern Alert System - newser.com
United Therapeutics Executives Sell Shares - TradingView
United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Wells Fargo Maintains United Therapeutics (UTHR) Equal-Weight Recommendation - Nasdaq
United Therapeutics (NASDAQ:UTHR) Reaches New 12-Month High After Better-Than-Expected Earnings - MarketBeat
United Therapeutics price target raised to $587 from $569 at RBC Capital - TipRanks
United Therapeutics price target raised to $447 from $435 at Morgan Stanley - TipRanks
United Therapeutics (UTHR) Earnings Transcript - AOL.com
United Therapeutics Corporation (NASDAQ:UTHR) Q3 2025 Earnings Call Transcript - Insider Monkey
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - MSN
United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - MSN
Silver Spring-based United Therapeutics reports Q3 earnings - Maryland Daily Record
Published on: 2025-10-31 23:58:52 - newser.com
United Therapeutics Reports Record Q3 2025 Results - TipRanks
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus
United Therapeutics: Q3 Earnings Snapshot - CT Insider
United Therapeutics (NASDAQ:UTHR) COO Sells $9,393,750.00 in Stock - MarketBeat
Why Is United Therapeutics (UTHR) Stock Soaring Today - Yahoo Finance
United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark - TradingView
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday - Benzinga
United Therapeutics Q3 2025 Earnings ReportRevenue & Profit AnalysisNews and Statistics - IndexBox
United Therapeutics Q3 2025 Earnings: Profit Beats ForecastsNews and Statistics - IndexBox
United Therapeutics (UTHR) Beats Q3 Earnings Estimates - Yahoo Finance
United Therapeutics Grows Revenue, But Misses Earnings Forecast - Finimize
United Therapeutics Corp Q3 2025 Earnings: EPS of $7.16 Beats Es - GuruFocus
United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings - Yahoo Finance
United Therapeutics Corp Announces Rise In Q3 Bottom Line - Nasdaq
United Therapeutics misses Q3 expectations despite record revenue - Investing.com
United Therapeutics misses Q3 expectations despite record revenue By Investing.com - Investing.com Philippines
United Therapeutics Q3 revenue misses estimates - TradingView
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results - TradingView
UNITED THERAPEUTICS Corp SEC 10-Q Report - TradingView
Sumitomo Mitsui Trust Group Inc. Has $28.81 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
United Therapeutics Corp. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Will United Therapeutics Corporation stock outperform value stocksTrade Performance Summary & Community Verified Swing Trade Signals - fcp.pa.gov.br
Can United Therapeutics Corporation stock resist sector downturnsPortfolio Risk Summary & AI Enhanced Market Trend Forecasts - fcp.pa.gov.br
How geopolitical tensions affect United Therapeutics Corporation stock2025 Support & Resistance & Daily Stock Trend Reports - fcp.pa.gov.br
United Therapeutics’ Promising Study on Inhaled Treprostinil for Lung Disease - TipRanks
United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks
United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients - TipRanks
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):